Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

Dollar Tree Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Published 12/03/2024, 16:11
Updated 12/03/2024, 17:40
© Reuters.  Dollar Tree Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Dollar Tree, Inc. (NASDAQ: DLTR) is expected to release its financial results for its fourth quarter, before the opening bell on March 13, 2024.

Analysts expect the Chesapeake, Virginia-based company to report quarterly earnings at $2.65 per share, up from $2.04 per share in the year-ago period. Dollar Tree is projected to post revenue of $8.67 billion for the latest quarter, compared to $7.72 billion in the year-earlier quarter, according to data from Benzinga Pro.

On Nov. 29, Dollar Tree reported third-quarter FY23 sales growth of 5.4% year-on-year to $7.31 billion, missing the analyst consensus of $7.40 billion.

Dollar Tree shares gained 0.7% to close at $149.00 on Monday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.

  • Guggenheim analyst John Heinbockel maintained a Buy rating and boosted the price target from $155 to $170 on March 5, 2024. This analyst has an accuracy rate of 60%.
  • Wells Fargo analyst Edward Kelly maintained an Overweight rating and raised the price target from $160 to $180 on March 4, 2024. This analyst has an accuracy rate of 69%.
  • JP Morgan analyst Matthew Boss upgraded the stock from Neutral to Overweight and boosted the price target from $122 to $157 on Jan. 29, 2024. This analyst has an accuracy rate of 68%.
  • Truist Securities analyst Scot Ciccarelli maintained a Buy rating and raised the price target from $135 to $149 on Dec. 21, 2023. This analyst has an accuracy rate of 80%.
  • Morgan Stanley analyst Simeon Gutman maintained an Equal-Weight rating and cut the price target from $140 to $135 on Nov. 30, 2023. This analyst has an accuracy rate of 61%.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Read This Next: Cramer Says This Healthcare Stock Can Go Higher, Calls Manhattan Associates 'A Winner'

Latest Ratings for DLTR

Mar 2022Loop CapitalUpgradesHoldBuy
Mar 2022Piper SandlerUpgradesNeutralOverweight
Mar 2022Deutsche BankMaintainsBuy

View the Latest Analyst Ratings

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.